Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2006-07-14

FDA Approved: ANDROGEL — Supplemental Application (ASCEND Therapeutics U.S., LLC)

View source ↗

Summary

Supplemental FDA submission for ANDROGEL (testosterone) by ASCEND Therapeutics U.S., LLC. The filing appears to involve labeling changes to the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ANDROGEL (Testosterone)

Snippet

SUPPL AP for ANDROGEL (TESTOSTERONE)